Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
Lot specific
Buffer
NUFIP1 antibody in PBS (3.0 mM KCl, 1.5 mM KH2 PO4 , 140 mM NaCl, 8.0 mM Na2 HPO4 (pH 7.4)) containing 1 % bovine serum albumin (BSA) and 0.05 % sodium azide (NaN3 ).
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 2-8 °C for up to one year. We recommend long term storage at -20 °C.
Target
NUFIP1
(Nuclear Fragile X Mental Retardation Protein Interacting Protein 1 (NUFIP1))
nufip antikoerper, MGC154944 antikoerper, NUFIP antikoerper, bA540M5.1 antikoerper, Nufip antikoerper, NUFIP1, FMR1 interacting protein 1 antikoerper, nuclear fragile X mental retardation protein interacting protein 1 antikoerper, nuclear fragile X mental retardation protein interacting protein 1 S homeolog antikoerper, NUFIP1 antikoerper, nufip1 antikoerper, nufip1.S antikoerper, Nufip1 antikoerper
Hintergrund
The NUFIP1 gene encodes the nuclear fragile X mental retardation-interacting protein, NUFIP1 has also been shown to interact with FMR1, Cyclin T1 and BRCA1. Synonyms: Monoclonal NUFIP1 antibody, Anti-NUFIP1 antibody, Nuclear fragile X mental retardation-interacting protein 1 antibody, NUFIP antibody.